Intra-Cellular Therapies Inc
F:23I
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Intra-Cellular Therapies Inc
F:23I
|
US |
|
I
|
Itissalat Al Maghrib Ste SA
XMUN:MSPA
|
MA |
|
V
|
Varca Ventures Inc
OTC:VRCV
|
US |
Shareholder Yield
Current shareholder yield for
23I is
.
Peers Comparison
Shareholder Yield
Price Appreciation
23I Price
Intra-Cellular Therapies Inc
| Average Annual Return | 39% |
| Standard Deviation of Annual Returns | 37.54% |
| Max Drawdown | -5% |
| Market Capitalization | 14B EUR |
| Shares Outstanding | 105 575 000 |
| Percentage of Shares Shorted |
N/A
|